Literature DB >> 30872293

Lesson of the month 1: A rare adverse reaction between flucloxacillin and paracetamol.

William Osborne1, Aneeka Chavda2, George Katritsis3, Jon S Friedland4.   

Abstract

Flucloxacillin, a beta-lactam antibiotic, is a commonly prescribed antibiotic for the treatment of infections caused by staphylococci and streptococci, most notably Staphylococcus aureus Paracetamol is one of the most dispensed medications by NHS England and is used for the treatment of fever and pain.1 However most doctors are unaware that concurrent use of these drugs can cause a potentially fatal drug interaction due to pyroglutamic acidosis (PGA), also known as 5-oxoprolinaemia. PGA is a rare cause of raised anion gap metabolic acidosis due to disruption of the γ-glutamyl cycle. We report the case of a patient with multiple comorbidities who developed PGA due to coadministration of paracetamol and flucloxacillin. © Royal College of Physicians 2019. All rights reserved.

Entities:  

Keywords:  5-oxoprolinaemia; Pyroglutamic acidosis; adverse drug reaction; flucloxacillin; metabolic acidosis; paracetamol

Year:  2019        PMID: 30872293      PMCID: PMC6454371          DOI: 10.7861/clinmedicine.19-2-127

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  9 in total

1.  Acquired 5-oxoproline acidemia successfully treated with N-acetylcysteine.

Authors:  Gregory L Hundemer; Andrew Z Fenves
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

2.  Association between paracetamol and pyroglutamic aciduria.

Authors:  J Pitt
Journal:  Clin Chem       Date:  1990-01       Impact factor: 8.327

3.  Sex differences in the subunits of glutathione-S-transferase isoenzyme from rat and human kidney.

Authors:  L Butera; D A Feinfeld; M Bhargava
Journal:  Enzyme       Date:  1990

4.  Mind the gap! An unusual metabolic acidosis.

Authors:  Katherine Myall; James Sidney; Aidan Marsh
Journal:  Lancet       Date:  2011-02-05       Impact factor: 79.321

5.  Pyroglutamicaciduria from vigabatrin.

Authors:  J R Bonham; J M Rattenbury; A Meeks; R J Pollitt
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

6.  Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis.

Authors:  G A Dempsey; H J Lyall; C F Corke; C D Scheinkestel
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

7.  Pyroglutamic acidemia in an adult patient.

Authors:  M H Creer; B W Lau; J D Jones; K M Chan
Journal:  Clin Chem       Date:  1989-04       Impact factor: 8.327

Review 8.  Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle.

Authors:  Michael Emmett
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

Review 9.  Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen.

Authors:  Andrew Z Fenves; Haskell M Kirkpatrick; Viralkumar V Patel; Lawrence Sweetman; Michael Emmett
Journal:  Clin J Am Soc Nephrol       Date:  2006-04-19       Impact factor: 8.237

  9 in total
  2 in total

1.  Adverse reactions.

Authors:  Michael Riste; George Trafford
Journal:  Clin Med (Lond)       Date:  2019-07       Impact factor: 2.659

2.  Severe acidosis due to 5-oxoprolinase inhibition by flucloxacillin in a patient with shoulder prosthesis joint infection.

Authors:  Julia Elisabeth Lenz; Volker Alt; Thomas Dienemann
Journal:  J Bone Jt Infect       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.